Impaired expression of excitatory amino acid transporter 2 (EAAT2) and glutamate homeostasis in canine necrotizing meningoencephalitis. 2008

Ngoc-Thi Pham, and Naoaki Matsuki, and Masahiro Shibuya, and Satoshi Tamahara, and Kenichiro Ono
Laboratory of Veterinary Clinical Pathobiology, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.

To clarify the involvement of excitatory and inhibitory amino acids in canine necrotizing meningoencephalitis (NME), glutamate, aspartate, taurine and gamma-aminobutylic acid (GABA) were determined in the cerebrospinal fluids (CSF) from eight NME cases and ten healthy controls. NME dogs exhibited significantly higher concentrations of glutamate and aspartate than those in controls (p<0.001 and p<0.001, respectively), while there was no difference in taurine or GABA between the two groups. When fetal canine astrocytes were cultured for 24 hr in the presence of NME-CSF, supernatant concentrations of glutamate, aspartate and taurine were significantly elevated. Simultaneously, expression of excitatory amino acid transporter 2 (EAAT2) mRNA was significantly reduced in the astrocytes without change in EAAT1 mRNA. Hence, reduced expression of EAAT2 and impaired glutamate homeostasis may contribute to the pathogenesis of NME.

UI MeSH Term Description Entries
D008297 Male Males
D004283 Dog Diseases Diseases of the domestic dog (Canis familiaris). This term does not include diseases of wild dogs, WOLVES; FOXES; and other Canidae for which the heading CARNIVORA is used. Canine Diseases,Canine Disease,Disease, Canine,Disease, Dog,Diseases, Canine,Diseases, Dog,Dog Disease
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004684 Leukoencephalitis, Acute Hemorrhagic A fulminant and often fatal demyelinating disease of the brain which primarily affects young adults and children. Clinical features include the rapid onset of weakness, SEIZURES, and COMA. It may follow a viral illness or MYCOPLASMA PNEUMONIAE infections but in most instances there is no precipitating event. Pathologic examination reveals marked perivascular demyelination and necrosis of white matter with microhemorrhages. (Adams et al., Principles of Neurology, 6th ed, pp924-5) Encephalitis, Acute Necrotizing,Hurst Disease,Necrotizing Hemorrhagic Encephalomyelitis,Acute Hemorrhagic Encephalomyelitis,Acute Hemorrhagic Leukoencephalitis,Encephalomyelitis, Acute Necrotizing Hemorrhagic,Encephalomyelitis, Hemorrhagic Necrotizing,Encephalomyelitis, Necrotizing Hemorrhagic,Hemorrhagic Encephalomyelitis, Necrotizing,Hemorrhagic Necrotizing Encephalomyelitis,Hurst Syndrome,Hurst's Disease,Leukoencephalitis Acuta Hemorrhagica,Leukoencephalitis, Subacute Hemorrhagic,Necrotizing Encephalomyelitis, Hemorrhagic,Acute Hemorrhagic Encephalomyelitides,Acute Hemorrhagic Leukoencephalitides,Acute Necrotizing Encephalitides,Acute Necrotizing Encephalitis,Disease, Hurst,Disease, Hurst's,Encephalitides, Acute Necrotizing,Encephalomyelitides, Acute Hemorrhagic,Encephalomyelitides, Hemorrhagic Necrotizing,Encephalomyelitis, Acute Hemorrhagic,Hemorrhagic Encephalomyelitides, Acute,Hemorrhagic Encephalomyelitides, Necrotizing,Hemorrhagic Encephalomyelitis, Acute,Hemorrhagic Leukoencephalitides, Acute,Hemorrhagic Leukoencephalitides, Subacute,Hemorrhagic Leukoencephalitis, Acute,Hemorrhagic Leukoencephalitis, Subacute,Hursts Disease,Leukoencephalitides, Acute Hemorrhagic,Leukoencephalitides, Subacute Hemorrhagic,Necrotizing Encephalitides, Acute,Necrotizing Encephalitis, Acute,Necrotizing Encephalomyelitides, Hemorrhagic,Necrotizing Hemorrhagic Encephalomyelitides,Subacute Hemorrhagic Leukoencephalitides,Subacute Hemorrhagic Leukoencephalitis,Syndrome, Hurst
D005260 Female Females
D005680 gamma-Aminobutyric Acid The most common inhibitory neurotransmitter in the central nervous system. 4-Aminobutyric Acid,GABA,4-Aminobutanoic Acid,Aminalon,Aminalone,Gammalon,Lithium GABA,gamma-Aminobutyric Acid, Calcium Salt (2:1),gamma-Aminobutyric Acid, Hydrochloride,gamma-Aminobutyric Acid, Monolithium Salt,gamma-Aminobutyric Acid, Monosodium Salt,gamma-Aminobutyric Acid, Zinc Salt (2:1),4 Aminobutanoic Acid,4 Aminobutyric Acid,Acid, Hydrochloride gamma-Aminobutyric,GABA, Lithium,Hydrochloride gamma-Aminobutyric Acid,gamma Aminobutyric Acid,gamma Aminobutyric Acid, Hydrochloride,gamma Aminobutyric Acid, Monolithium Salt,gamma Aminobutyric Acid, Monosodium Salt
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001224 Aspartic Acid One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter. (+-)-Aspartic Acid,(R,S)-Aspartic Acid,Ammonium Aspartate,Aspartate,Aspartate Magnesium Hydrochloride,Aspartic Acid, Ammonium Salt,Aspartic Acid, Calcium Salt,Aspartic Acid, Dipotassium Salt,Aspartic Acid, Disodium Salt,Aspartic Acid, Hydrobromide,Aspartic Acid, Hydrochloride,Aspartic Acid, Magnesium (1:1) Salt, Hydrochloride, Trihydrate,Aspartic Acid, Magnesium (2:1) Salt,Aspartic Acid, Magnesium-Potassium (2:1:2) Salt,Aspartic Acid, Monopotassium Salt,Aspartic Acid, Monosodium Salt,Aspartic Acid, Potassium Salt,Aspartic Acid, Sodium Salt,Calcium Aspartate,Dipotassium Aspartate,Disodium Aspartate,L-Aspartate,L-Aspartic Acid,Magnesiocard,Magnesium Aspartate,Mg-5-Longoral,Monopotassium Aspartate,Monosodium Aspartate,Potassium Aspartate,Sodium Aspartate,Aspartate, Ammonium,Aspartate, Calcium,Aspartate, Dipotassium,Aspartate, Disodium,Aspartate, Magnesium,Aspartate, Monopotassium,Aspartate, Monosodium,Aspartate, Potassium,Aspartate, Sodium,L Aspartate,L Aspartic Acid
D001253 Astrocytes A class of large neuroglial (macroglial) cells in the central nervous system - the largest and most numerous neuroglial cells in the brain and spinal cord. Astrocytes (from "star" cells) are irregularly shaped with many long processes, including those with "end feet" which form the glial (limiting) membrane and directly and indirectly contribute to the BLOOD-BRAIN BARRIER. They regulate the extracellular ionic and chemical environment, and "reactive astrocytes" (along with MICROGLIA) respond to injury. Astroglia,Astroglia Cells,Astroglial Cells,Astrocyte,Astroglia Cell,Astroglial Cell,Astroglias,Cell, Astroglia,Cell, Astroglial
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

Ngoc-Thi Pham, and Naoaki Matsuki, and Masahiro Shibuya, and Satoshi Tamahara, and Kenichiro Ono
April 2001, Forensic science international,
Ngoc-Thi Pham, and Naoaki Matsuki, and Masahiro Shibuya, and Satoshi Tamahara, and Kenichiro Ono
October 2011, Journal of cellular physiology,
Ngoc-Thi Pham, and Naoaki Matsuki, and Masahiro Shibuya, and Satoshi Tamahara, and Kenichiro Ono
February 2003, Proceedings of the National Academy of Sciences of the United States of America,
Ngoc-Thi Pham, and Naoaki Matsuki, and Masahiro Shibuya, and Satoshi Tamahara, and Kenichiro Ono
January 2023, Metabolic brain disease,
Ngoc-Thi Pham, and Naoaki Matsuki, and Masahiro Shibuya, and Satoshi Tamahara, and Kenichiro Ono
October 2010, The Journal of biological chemistry,
Ngoc-Thi Pham, and Naoaki Matsuki, and Masahiro Shibuya, and Satoshi Tamahara, and Kenichiro Ono
March 2020, The Journal of biological chemistry,
Ngoc-Thi Pham, and Naoaki Matsuki, and Masahiro Shibuya, and Satoshi Tamahara, and Kenichiro Ono
December 1999, British journal of pharmacology,
Ngoc-Thi Pham, and Naoaki Matsuki, and Masahiro Shibuya, and Satoshi Tamahara, and Kenichiro Ono
August 2022, Nature communications,
Ngoc-Thi Pham, and Naoaki Matsuki, and Masahiro Shibuya, and Satoshi Tamahara, and Kenichiro Ono
February 2002, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Copied contents to your clipboard!